GALE

gene product
SDR1E1
This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
41 antibodies from 14 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Aviva Systems Biology
4 antibodies
antibodies-online
2 antibodies
Abnova Corporation
5 antibodies
Novus Biologicals
8 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
Acris Antibodies GmbH
6 antibodies
Epitomics
2 antibodies
GeneTex
2 antibodies
OriGene
1 antibody
Thermo Fisher Scientific Pierce
1 antibody
LifeSpan BioSciences, Inc.
2 antibodies
Sigma-Aldrich
2 antibodies
Creative Biomart
4 antibodies